Guizhou Yibai Pharmaceutical Co.,Ltd.’s Net Profit Dropped 16.9% in First Three Quarters of 2023

Guizhou Yibai Pharmaceutical Co.,Ltd. (贵州益佰制药股份有限公司) (600594.SH) reported a net profit of 161.5 million yuan in the first three quarters of 2023, down 16.9% year-on-year.

Meanwhile, the company posted 2.1 billion yuan in revenue, up 1.8% year-on-year.

At the end of the reporting period, it had 4.9 billion yuan in total assets and 1.5 billion yuan in total liabilities, with a liability-to-asset ratio of 31.6%.